Bayzed Health Group Inc (HKG:2609)

Bayzed Health Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,189	1,072	802.65	461.59
Revenue Growth (YoY)	10.88%	33.58%	73.89%	-
Cost of Revenue	980.65	894.01	723.1	420.2
Gross Profit	208.2	178.16	79.56	41.39
Selling, General & Admin	177.53	160.64	120.61	82.54
Other Operating Expenses	-2.13	-4.17	-3.75	-1.6
Operating Expenses	176.05	156.74	118.92	81.4
Operating Income	32.15	21.42	-39.36	-40.01
Interest Expense	-21.5	-26.66	-23.62	-20.95
Interest & Investment Income	2.84	1.19	1.32	5.9
Other Non Operating Income (Expenses)	-0.18	-0.39	-0.82	-0.11
EBT Excluding Unusual Items	13.31	-4.43	-62.48	-55.17
Gain (Loss) on Sale of Assets	0	-0.18	-0.04	0.33
Pretax Income	13.31	-4.61	-62.52	-54.84
Income Tax Expense	16.87	19.8	12.99	7.12
Earnings From Continuing Operations	-3.56	-24.41	-75.52	-61.96
Minority Interest in Earnings	-9.9	-1.98	17.5	15.86
Net Income	-13.46	-26.39	-58.02	-46.09
Net Income to Common	-13.46	-26.39	-58.02	-46.09
Shares Outstanding (Basic)	1,185	1,185	-	-
Shares Outstanding (Diluted)	1,185	1,185	-	-
EPS (Basic)	-0.01	-0.02	-	-
EPS (Diluted)	-0.01	-0.02	-	-
Free Cash Flow	124.67	83	84.96	-42.65
Free Cash Flow Per Share	0.10	0.07	-	-
Gross Margin	17.51%	16.62%	9.91%	8.97%
Operating Margin	2.70%	2.00%	-4.90%	-8.67%
Profit Margin	-1.13%	-2.46%	-7.23%	-9.98%
Free Cash Flow Margin	10.49%	7.74%	10.59%	-9.24%
EBITDA	90.84	80.99	10.62	-8.77
EBITDA Margin	7.64%	7.55%	1.32%	-1.90%
D&A For EBITDA	58.69	59.57	49.98	31.24
EBIT	32.15	21.42	-39.36	-40.01
EBIT Margin	2.70%	2.00%	-4.90%	-8.67%
Effective Tax Rate	126.72%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.